Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial

By Kaku Kohei  

Current Medical Research and Opinion, Vol. 25, Iss. 5, 2009-05 ,pp. : 1111-1119

Informa Healthcare

Access to resources Recommend Favorite

Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial

By Umpierrez Guillermo   Issa Maher   Vlajnic Aleksandra  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 751-759

Informa Healthcare

Access to resources Recommend Favorite

Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus

By Pandya Bhavik J.   Bron Morgan   McCall Therese   Yu Andrew P.   Chen Kristina S.   Mattson Miles E.   Wu Eric Q.  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 189-195

Informa Healthcare

Access to resources Recommend Favorite

Saxagliptin and metformin XR combination therapy provides glycemic control over 24 hours in patients with T2DM inadequately controlled with metformin

By Stenlöf Kaj   Raz Itamar   Neutel Joel   Ravichandran Shoba   Berglind Niklas   Chen Roland  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2355-2363

Informa Healthcare

Access to resources Recommend Favorite

Effects of early use of pioglitazone in combination with metformin in patients with newly diagnosed type 2 diabetes

By Chalmers J.   Hunter J. E.   Robertson S. J.   Baird J.   Martin M.   Franks C. I.   Whately-Smith C. R.   Mariz S.   Campbell I. W.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1775-1781

Informa Healthcare

Access to resources Recommend Favorite